Abstract
Summary
Intraperitoneally injected 35SO4ppeared rapidly in the blood and in the prostate glands of the 2-year-old mouse. Most of the prostate 35S was in the tissue proper with small amounts in the blood. The amounts of soluble 35S of prostate glands were greatest at 1 hr and least at 125 hr after 35S injection. The amounts of nonsolu-ble 35S (not removable by washing with formalin solution) decreased much more gradually than the soluble 35S. Consequently, the nonsoluble 35S amounted to 1 % of the total prostate 35S at 1 hr and to about 100% at 125 hr.
The amounts of nonsoluble 35S were the same for both the ventral and lateral prostatic lobes at the various time points after the injection. The nonsoluble 35S increased to a peak at 5 hr, decreased to half the peak at 25 hr, and it continued to decrease with time.
At 10 min after its injection, 35S was detectable in the epithelial cells and lumen of the acinus by radioautography. The amounts of 35S in the epithelial cells increased from relatively large at 1 hr to massive amounts at 5 hr. However, at 50 hr, the 35S in the epithelial cells had decreased to the 10-min level while the amounts in the lumina had greatly increased.
Results of this investigation suggest that the nonsoluble prostate 35S was initially concentrated in the acinar cells, moved into the lumen, and then was excreted by the prostate gland. Thus, the prostate gland of the 2-year-old mouse is physiologically active and capable of metabolizing 35S04.
The water-, ethanol-, .xylene-, and metha-nol-insoluble 35S of the prostate gland appears to be an integral component of GAGs.
Get full access to this article
View all access options for this article.
